XML 82 R66.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-based Compensation (Details)
12 Months Ended
Dec. 31, 2016
USD ($)
plan
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2014
USD ($)
$ / shares
shares
May 22, 2013
shares
Dec. 31, 2003
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of compensation plans | plan 2        
Total stock-based compensation expense | $ $ 16,200,000 $ 22,500,000 $ 13,400,000    
Fair value assumptions and methodology [Abstract]          
Expected volatility range of stock, minimum (in hundredths)   34.00% 56.70%    
Expected volatility range of stock, maximum (in hundredths)   36.20% 66.50%    
Expected life of option, range in years, minimum   3 years 2 years    
Expected life of option, range in years, maximum   5 years 4 years    
Risk-free interest rate range, minimum (in hundredths)   0.90% 0.40%    
Risk-free interest rate range, maximum (in hundredths)   1.50% 1.40%    
Expected dividend yield on stock, minimum (in hundredths)   0.00% 0.60%    
Expected dividend yield on stock, maximum (in hundredths)   0.00% 0.70%    
Weighted Average Exercise Price          
Total intrinsic value of options exercised | $ 23,900,000 $ 71,800,000 $ 6,700,000    
Total unrecognized stock-based compensation expense | $ $ 31,400,000        
Weighted Average Remaining Vesting Period (in years) 2 years 6 months 15 days        
Cash received from exercise of stock options | $ $ 15,700,000 $ 20,400,000 $ 4,300,000    
Treasury Stock          
Shares          
Released (in shares) (600,000) (1,300,000) (200,000)    
Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Total stock-based compensation expense | $ $ 5,300,000 $ 6,600,000 $ 7,000,000    
Shares          
Granted (in shares) 0        
Weighted Average Exercise Price          
Total unrecognized stock-based compensation expense | $ $ 5,300,000        
Weighted Average Remaining Vesting Period (in years) 1 year 6 months 4 days        
Performance-based Restricted Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Total stock-based compensation expense | $ $ 3,900,000 13,700,000 3,500,000    
Revaluation benefit from PRSU Granted | $ $ 3,800,000 $ 0 $ 3,000,000    
Shares          
Beginning balance (in shares) 1,900,000 300,000      
Granted (in shares) 200,000 1,700,000      
Vested (in shares) (100,000) 0      
Forfeited/Terminated (in shares) (300,000) (100,000)      
Ending balance (in shares) 1,700,000 1,900,000 300,000    
Weighted Average Grant Date Fair Value          
Beginning balance (in dollars per share) | $ / shares $ 68.17 $ 53.45      
Granted (in dollars per share) | $ / shares 60.78 70.43      
Vested (in dollars per share) | $ / shares 51.87 0.00      
Forfeited/Terminated (in dollars per share) | $ / shares 70.43 56.74      
Ending balance (in dollars per share) | $ / shares $ 68.02 $ 68.17 $ 53.45    
Outstanding intrinsic value | $ $ 121,200,000        
Weighted Average Exercise Price          
Total unrecognized stock-based compensation expense | $ $ 14,200,000        
Weighted Average Remaining Vesting Period (in years) 2 years 6 months 22 days        
Performance-based Restricted Stock Units | 2018 if target is not met          
Weighted Average Grant Date Fair Value          
Percentage of target shares to vest 33.33%        
Performance-based Restricted Stock Units | Treasury Stock          
Weighted Average Grant Date Fair Value          
Grant date intrinsic value | $ $ 5,600,000 $ 0 $ 1,400,000    
Performance period (in years) 2 years   1 year    
Percentage of stock units released 79.00%   100.00%    
Maximum payout (percent) 200.00%        
Performance-based Restricted Stock Units | Chief Executive Officer | 2018 if target is not met          
Weighted Average Grant Date Fair Value          
Percentage of target shares to vest   33.33%      
Performance-based Restricted Stock Units | December 31, 2017 if target is met          
Weighted Average Grant Date Fair Value          
Number of Shares Granted 100,000        
Maximum Number of Shares to be Awarded 100,000        
Performance-based Restricted Stock Units | Five annual installments beginning on each applicable grant date          
Weighted Average Grant Date Fair Value          
Number of Shares Granted 100,000        
Maximum Number of Shares to be Awarded 100,000        
Restricted Stock Units and Deferred Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Total stock-based compensation expense | $ $ 7,000,000 $ 2,200,000 $ 2,900,000    
Shares          
Beginning balance (in shares) 100,000 100,000      
Granted (in shares) 300,000 100,000      
Vested (in shares) 0 (100,000)      
Forfeited/Terminated (in shares) 0 0      
Ending balance (in shares) 400,000 100,000 100,000    
Weighted Average Grant Date Fair Value          
Beginning balance (in dollars per share) | $ / shares $ 66.41 $ 50.41      
Granted (in dollars per share) | $ / shares 53.77 70.44      
Vested (in dollars per share) | $ / shares 60.17 58.73      
Forfeited/Terminated (in dollars per share) | $ / shares 53.45 49.63      
Ending balance (in dollars per share) | $ / shares $ 59.37 $ 66.41 $ 50.41    
Weighted Average Exercise Price          
Aggregate intrinsic value of units outstanding | $ $ 27,100,000        
Aggregate intrinsic value of RSUs and DSUs vested during the period | $ 700,000        
Total unrecognized stock-based compensation expense | $ $ 11,900,000        
Weighted Average Remaining Vesting Period (in years) 2 years 11 months 19 days        
Unvested Stock Options          
Shares          
Beginning balance (in shares) 800,000 500,000      
Granted (in shares) 0 800,000      
Vested (in shares) (300,000) (400,000)      
Forfeited (in shares) 0 (100,000)      
Ending balance (in shares) 500,000 800,000 500,000    
Weighted Average Grant Date Fair Value          
Beginning of period weighted average grant date fair value (dollars per share) | $ / shares $ 62.34 $ 46.23      
Granted weighted average grant date fair value (dollars per share) | $ / shares 0.00 63.55      
Vested weighted average grant date fair value (dollars per share) | $ / shares 61.28 44.25      
Forfeited weighted average grant date fair value (dollars per share) | $ / shares 58.37 57.12      
Ending of period weighted average grant date fair value (dollars per share) | $ / shares $ 63.09 $ 62.34 $ 46.23    
Long Term Incentive Plan 2013          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Maximum number of common stock shares to be issued (in shares)       5,100,000  
Amended And Restated 2003 Equity Incentive Plan | Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Maximum number of common stock shares to be issued (in shares)         11,500,000
Aspirational Plan | Performance-based Restricted Stock Units | Chief Executive Officer          
Weighted Average Grant Date Fair Value          
Minimum Adjusted EBITDA (more than) | $   $ 650,000,000      
Unrecognized compensation expense | $ $ 4,400,000 $ 101,100,000      
Aspirational Plan | Performance-based Restricted Stock Units | Executive Officer          
Shares          
Granted (in shares) 72,000 1,390,000      
Stock Option Plans 2002, 2003 and 2013          
Shares          
Beginning balance (in shares) 2,100,000 2,800,000      
Granted (in shares) 0 800,000      
Released (in shares) (600,000) (1,400,000)      
Forfeited (in shares) 0 (100,000)      
Ending balance (in shares) 1,500,000 2,100,000 2,800,000    
Options exercisable (in shares) 1,000,000        
Weighted Average Exercise Price          
Beginning balance weighted average exercise price (dollars per share) | $ / shares $ 42.75 $ 24.18      
Granted weighted average exercise price (dollars per share) | $ / shares 0.00 63.55      
Released weighted average exercise price (in dollars per share) | $ / shares 24.72 14.70      
Forfeited weighted average exercise price (dollars per share) | $ / shares 58.37 57.12      
Ending balance weighted average exercise price (dollars per share) | $ / shares 50.46 $ 42.75 $ 24.18    
Options exercisable weighted average exercise price (dollars per share) | $ / shares $ 44.45        
Ending balance weighted average remaining contractual term (in years) 6 years 8 months 16 days        
Options exercisable weighted average remaining contractual term (in years) 5 years 11 months 23 days        
Ending balance aggregate intrinsic value | $ $ 19,100,000        
Options exercisable aggregate intrinsic value | $ $ 23,600,000